In this study, based on the hypothesis that individuals carrying certain polymorphisms in the LQT genes may be at risk of life-threatening arrhythmias if exposed to psychotropic drugs that block ...

LQT Therapeutics wants to tackle debilitating heart arrhythmias with limited interventions, and investors are planting a seed in the biotech's heart with $19 million. The two-year-old Canadian ...